Name: Christopher McGinnis
Previous title: CEO, CitizensRx
New title: CFO, GoodRx
Christopher McGinnis has recently been appointed as the Chief Financial Officer of GoodRx, a leading prescription price transparency company. He officially assumed his new role on Tuesday, as announced in a press release by the company.
Prior to joining GoodRx, McGinnis served as the CEO of CitizensRx, a midsized pharmacy benefit manager, for nearly four years. His extensive experience in the healthcare industry also includes leadership positions at Lumeris, a value-based care firm, and Express Scripts, one of the largest pharmacy benefit managers in the country.
McGinnis takes over the CFO position from Karsten Voermann, who resigned last month for personal reasons. Romin Nabiey, the company’s chief accounting officer, had been serving as the interim CFO during the transition period.
GoodRx recently appointed Wendy Barnes as the new CEO, who assumed the role on January 1. Barnes, formerly of Express Scripts, replaced the company’s co-CEOs Trevor Bezdek and Doug Hirsch. Both Bezdek and Hirsch now sit on GoodRx’s board of directors alongside Scott Wagner, who was the interim CEO before Barnes.
Despite starting the year with a lower stock price, GoodRx reported a revenue of $195.3 million in the third quarter, marking an over 8% increase year over year. The company also posted a net income of nearly $4 million, a significant improvement from the previous year’s loss of $38.5 million.
Investors and stakeholders are eagerly awaiting GoodRx’s fourth-quarter earnings report, scheduled to be released on February 27.
